Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion type Assertion NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_head.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion wasGeneratedBy ECO_0000203 NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_provenance.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion wasDerivedFrom befree-2016 NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_provenance.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion SIO_000772 21911423 NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_provenance.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion evidence source_evidence_literature NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_provenance.
- NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_assertion description "[Chronic myeloid leukemia (CML) is induced by the oncogenic BCR-ABL1 tyrosine kinase and can be effectively treated for many years with tyrosine kinase inhibitors (TKIs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923247.RAFhcw6a1zr66B2bxTpFM6ZpJSpviSieBmDcr_uL1J23s130_provenance.